Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2017-10-12 Director's Dealing
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is explicitly marked with an 'RNS Number' and contains a notification regarding a 'Director/PDMR Shareholding' transaction (purchase of shares by a Non-Executive Director). This type of filing, which reports insider transactions, directly corresponds to the definition of Director's Dealing. The presence of the RNS header suggests it was released via the London Stock Exchange's Regulatory News Service, but the specific content dictates the classification should be DIRS, not the general RNS fallback.
2017-10-12 English
Hardman Research: Continuing to gain market share
Regulatory Filings Classification · 99% confidence The document is very short (3280 characters) and explicitly states that it is providing 'Additional information' via an 'RNS Number : 1249T'. The content summarizes research findings ('Hardman Research: Continuing to gain market share') and directs the reader to a PDF link for the 'full report'. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing or linking to a full report is classified as a Report Publication Announcement (RPA). The presence of the RNS header and the concluding line 'This information is provided by RNS' further supports this, but RPA is more specific than the general RNS fallback because it is clearly announcing the publication of external research.
2017-10-10 English
Preliminary Results
Earnings Release Classification · 100% confidence The document explicitly states: 'Allergy Therapeutics plc... today announces preliminary results for the year ended 30 June 2017.' It provides detailed financial highlights, operational highlights, and commentary from the CEO and Chairman covering the full fiscal year. This content strongly indicates a comprehensive annual financial report. However, the document also contains a section titled 'CHAIRMAN'S STATEMENT' which introduces the 'Group's Annual Report & Accounts for the year ended 30 June 2017.' The presence of the preliminary results announcement followed by the Chairman's statement, which references the full 'Annual Report & Accounts,' suggests this document is either the full Annual Report (10-K equivalent for non-US filers) or a very detailed precursor/summary. Given the length (82k characters) and the inclusion of detailed operational and governance reviews alongside the preliminary results, it aligns best with the comprehensive nature of an Annual Report (10-K). The RNS number suggests it was initially released via a regulatory news service, but the content itself is the annual report narrative and results summary, not just a brief announcement of publication (RPA). FY 2017
2017-09-28 English
Approval for PQ Grass Phase II trial
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated September 18, 2017. The content announces the 'Approval of clinical trial application for PQ Grass Phase II trial' and discusses clinical development progress, market potential, and expected results timelines. The document concludes with an explicit statement: 'This information is provided by RNS The company news service from the London Stock Exchange'. This structure and explicit source identification strongly indicate a general regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). Since the content is a specific operational update (clinical trial approval) that doesn't fit neatly into the defined categories like ER, 10-K, or CAP, the most appropriate classification is the general regulatory filing fallback category.
2017-09-18 English
Expansion of Clinical Development and R&D teams
Board/Management Information Classification · 99% confidence The document is identified by the 'RNS Number' header and the concluding statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces senior appointments and expansion of the R&D and clinical teams, which constitutes an announcement regarding management/personnel changes. This aligns best with the 'Board/Management Information' category (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Since it is a specific announcement type, RNS is not the primary classification, but MANG is.
2017-09-11 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is very short (2553 characters) and explicitly states that the company "will issue its preliminary results for the year ended 30 June 2017 on Thursday 28 September 2017." It also mentions a presentation and conference call for analysts on the day of the results. This structure—announcing the future release date of a report (Preliminary Results, which are similar to an Earnings Release or Interim Report) rather than containing the full results or the report itself—fits the definition of a Report Publication Announcement (RPA). It is not the full report (ER or IR), nor is it a general regulatory filing (RNS) since a more specific category applies based on Rule 2.
2017-08-15 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.